Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 11, 2021

SELL
$5.19 - $7.38 $2,439 - $3,468
-470 Closed
0 $0
Q1 2021

May 12, 2021

BUY
$5.65 - $7.66 $2,655 - $3,600
470 New
470 $3,000
Q2 2019

Aug 09, 2019

SELL
$2.48 - $3.76 $41,931 - $63,574
-16,908 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$2.84 - $4.18 $48,018 - $70,675
16,908 New
16,908 $51,000

Others Institutions Holding SCPH

About scPharmaceuticals Inc.


  • Ticker SCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 27,402,100
  • Market Cap $97M
  • Description
  • scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...
More about SCPH
Track This Portfolio

Track Panagora Asset Management Inc Portfolio

Follow Panagora Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.